A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)
A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)
Enrolling by invitation · NCT05796440 · Registry updated 2024-02-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) | Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hypopituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder | Enrolling by invitation | Phase 2 | 2024-02-15 | NCT05796440 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lumos Pharma | 6 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Canberra Hospital | Garran | Australia | 23 |
| Children's Mercy Hospital | Kansas City | United States | 1 |
| Seattle Children's Hospital | Seattle | United States | 281 |
| Texas Tech University Health Sciences Center | Amarillo | United States | 1 |
| UMass Memorial Medical Center | Worcester | United States | 21 |
| University of Iowa | Iowa City | United States | 284 |
| University of South Carolina | Charleston | United States | 3 |